ADVENTIA PHARMA is selected for its innovative DNA to participate in Cajamar Wefood

3 de April de 2019

Adventia Pharma, the only Canarian company, selected to participate in Cajamar Wefood, a forum of trends in food, which is held on April 3 in Madrid whose objective is to discuss current challenges in food.

This meeting is a forum of opportunities that allows us to face the current situation and challenges of the food sector that contribute to human well-being. The topics to be discussed focus on biotechnology, microorganisms and ferments, natural ingredients and the new formats oriented to Consumption 4.0.

It is a showcase for innovative projects that respond to food trends. In addition, it is a space for meetings and contact between entrepreneurs, researchers, professionals, companies, technology centers and institutions that share an innovative spirit.

Adventia Pharma's participation led by Paqui Rivera, Director of Strategy and Business Development, focuses on explaining the company's innovative DNA and examples of milestones in innovation. Some of these examples are the following; Bi1 Aromas, a tool created to promote hydration of patients; the packaging of oral diets has the “easy to open” seal approved by the Swedish Rheumatism Association; only company in the market of the clinical nutrition that uses EVOO as a source of fat; We are also the only laboratory whose oral diets are certified by ADILAC (Association of Lactose Intolerant in Spain).

Likewise, Adventia Pharma's intervention addresses the challenges of future clinical nutrition and works to offer personalized clinical nutrition by developing proprietary technological solutions that will make possible a nutrition model that responds to these requirements: personalized nutrition, adapted to the needs and preferences of patients and consumers.

For more information about our products, call us on the phone (+34) 928 223 717 or
Copyright © 2024 Adventia Pharma. Todos los derechos reservados.